The roles of iNOS in liver ischemia-reperfusion injury. 2001

V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

To determine the contribution of the inducible nitric oxide synthase (iNOS) to hepatic injury following warm ischemia-reperfusion, we developed a model of partial hepatic ischemia-reperfusion in mice and studied the injury response in iNOS knockout (KO) mice. Compared with wild types, iNOS KO animals exhibited lower plasma transaminase levels after 1 and 6 h of reperfusion following 1 h of ischemia. At the 3-h time point, enzyme levels were not different between the two groups. iNOS mRNA was not detectable in the ischemic hepatic lobes of wild-type mice until 3 h of reperfusion; however, perfusion studies identified a significant delay in reperfusion of the ischemic lobe in the iNOS KO mice at the 1-h time point with similar perfusion rates at 3 and 6 h compared with wild type. By way of comparison, mice deficient in the endothelial NOS (eNOS) were also assessed for the degree of hepatic damage 3 h post-reperfusion. Plasma transaminase levels were significantly increased in eNOS KO animals compared with wild-type controls. These data suggest that systemic as well as local sources of iNOS regulate reperfusion, and local iNOS contributes to hepatic injury, while eNOS is protective in warm hepatic ischemia-reperfusion.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries

Related Publications

V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
February 2024, Journal of gastroenterology and hepatology,
V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
January 2005, Journal of investigative surgery : the official journal of the Academy of Surgical Research,
V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
January 2020, Biochemical and biophysical research communications,
V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
January 2020, Frontiers in cell and developmental biology,
V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
May 2019, Biochemical and biophysical research communications,
V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
January 1999, Bratislavske lekarske listy,
V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
January 2001, Postepy higieny i medycyny doswiadczalnej,
V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
May 2008, Frontiers in bioscience : a journal and virtual library,
V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
January 2019, Current protein & peptide science,
V G Lee, and M L Johnson, and J Baust, and V E Laubach, and S C Watkins, and T R Billiar
January 2011, Journal of clinical biochemistry and nutrition,
Copied contents to your clipboard!